Last $116.48 USD
Change Today +3.66 / 3.24%
Volume 6.1M
CELG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
NASDAQ GM
As of 4:30 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard H. Bagger

Former Senior Vice President of Corporate Affairs & Strategic Market Access, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 2 different industries.

See Board Relationships
53--

Background*

Mr. Richard H. Bagger, also known as Rick, served as Senior Vice President of Corporate Affairs & Strategic Market Access at Celgene Corporation since January 30, 2012. Mr. Bagger was responsible for advancing patient access to Celgene therapies and driving recognition of the value of Celgene innovation through government relations, communications, patient advocacy and market access policy activities around the world. He is a pharmaceutical industry and public affairs ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: 908-673-9001

Board Members Memberships*

2012-Present
Member of Board of Commissioners, Chairman of Finance Committee and Member of Audit Committee

Education*

JD
Rutgers Law School, Camden
BA
Woodrow Wilson School of Public and International Affairs

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $116.48 USD +3.66

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.